CHOLESTECH CORPORATION Contracts & Agreements

52 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
FORM OF CHOLESTECH CORPORATION AMENDMENT TO SEVERANCE AGREEMENT
Severance Agreements
CHOLESTECH CORPORATION
ETFs
CA
2007
FORM OF CHOLESTECH CORPORATION AMENDMENT TO CHANGE OF CONTROLSEVERANCE AGREEMENT
CHOLESTECH CORPORATION
2007
AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG INVERNESS MEDICAL INNOVATIONS, INC., IRIS MERGER SUB, INC. AND CHOLESTECH CORPORATION
Merger Agreements
CHOLESTECH CORPORATION
2007
Current assets
CHOLESTECH CORPORATION
2006
Current assets
CHOLESTECH CORPORATION
2006
Exhibit No
CHOLESTECH CORPORATION
2005
Exhibit No
CHOLESTECH CORPORATION
ETFs
CA
2005
Current assets
CHOLESTECH CORPORATION
2005
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $244 billion
CHOLESTECH CORPORATION
2005
Entry into a Material Definitive Agreement
CHOLESTECH CORPORATION
2005
Entry into a Material Definitive Agreement
CHOLESTECH CORPORATION
2005
Exhibit No
CHOLESTECH CORPORATION
2005
Lease Agreement Addendum No. One by and between Cholestech and BIV Group dated November 19, 2004
Lease Agreements
CHOLESTECH CORPORATION
ETFs
2004
Current assets
CHOLESTECH CORPORATION
2004
Current assets
CHOLESTECH CORPORATION
2004
CHOLESTECH CORPORATION SEVERANCE AGREEMENT
Severance Agreements
CHOLESTECH CORPORATION
2004
CHOLESTECH CORPORATION CHANGE OF CONTROL SEVERANCE AGREEMENT
Change of Control Agreements
CHOLESTECH CORPORATION
2004
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion
CHOLESTECH CORPORATION
2004
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion
CHOLESTECH CORPORATION
2004
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion
CHOLESTECH CORPORATION
ETFs
CA
2004
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion
CHOLESTECH CORPORATION
ETFs
CA
2004
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion
CHOLESTECH CORPORATION
2004
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion
CHOLESTECH CORPORATION
2004
FINANCIAL INFORMATION
CHOLESTECH CORPORATION
ETFs
2004
FINANCIAL INFORMATION
CHOLESTECH CORPORATION
ETFs
2004
FINANCIAL INFORMATION
CHOLESTECH CORPORATION
2004
FINANCIAL INFORMATION
CHOLESTECH CORPORATION
2004
FINANCIAL INFORMATION
CHOLESTECH CORPORATION
2004
FINANCIAL INFORMATION
CHOLESTECH CORPORATION
ETFs
CA
2004
FINANCIAL INFORMATION
CHOLESTECH CORPORATION
ETFs
CA
2003
FINANCIAL INFORMATION
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
CHOLESTECH CORPORATION
ETFs
CA
2001
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
CHOLESTECH CORPORATION
ETFs
2001
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
2003
Legal Proceedings
CHOLESTECH CORPORATION
ETFs
2002
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
CHOLESTECH CORPORATION
ETFs
CA
2001